4//SEC Filing
Berkenblit Anna 4
Accession 0001179110-21-001492
CIK 0000855654other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 8:09 PM ET
Size
5.4 KB
Accession
0001179110-21-001492
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Berkenblit Anna
VP & Chief Medical Officer
Transactions
- Award
Common Stock (right to buy)
2021-02-05$7.69/sh+282,019$2,168,726→ 282,019 totalExercise: $7.69From: 2022-02-05Exp: 2031-02-05→ Common Stock (282,019 underlying)
Footnotes (1)
- [F1]These options vest over a four-year period, with 25% of the shares vesting on the one year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant.
Documents
Issuer
ImmunoGen, Inc.
CIK 0000855654
Entity typeother
Related Parties
1- filerCIK 0001691868
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 8:09 PM ET
- Size
- 5.4 KB